by Comite Web | Oct 24, 2025 | Sin categorizar
IV ALIPANC Solidarity Gala
Friday, November 21 at 8:00 PM
Élkar Restaurant, Torre Emperador Castellana P.º de la Castellana, 259D, 33rd Floor, 28046 Madrid
Donation: €180 per person
Join the fight against pancreatic cancer
The Pancreatic Cancer Research Alliance in Spain (ALIPANC) invites you to the 4th edition of its Solidarity Gala, a charitable event held in honor of World Pancreatic Cancer Day.
This dinner aims to:
- Raise awareness about ALIPANC’s mission
- Collect funds for research
- Strengthen the commitment of our benefactors
ALIPANC brings together over 160 researchers from Spain and Portugal, working across hospitals and research centers in multicenter, multidisciplinary studies to improve the diagnosis, treatment, and survival of pancreatic cancer patients.
How can you help?
- Attend the gala: Share a meaningful evening with researchers, patients, and representatives from the business and public sectors.
- Support through “fila cero”: Contribute even if you cannot attend in person.
- Spread the word: Help raise public awareness about this disease.
Registration
Registration form https://forms.gle/EDhZkmVo7axLodzRA
Payment Options
- Bank transfer
IBAN: ES31 0182 9769 5102 0055 3107
- Bizum (Donate to NGO):
Code 10456
Formal attire requested.
by Comite Web | Oct 22, 2025 | Sin categorizar
On October 5–7, 2025, the annual United European Gastroenterology (UEG) Week in Berlin hosted the inaugural Digestive Disease Mechanisms (DDM) Summit, organized by Francisco X. Real, Mathias Heikenwälder, and Maria Sibilia. The DDM Summit marked the first basic research–focused program within UEG Week, which has traditionally been recognized for its clinical orientation. This new initiative aims to bridge the gap between clinicians and scientists, fostering translational collaboration across the fields of gastroenterology, hepatology, and pancreatic research.
The ALIPANC consortium was represented in Berlin by Francisco X. Real, Núria Malats, Chengsi Wu, and Mikhail Chesnokov. Chengsi Wu delivered an oral presentation on how gut microbiome dynamics shape pancreatic health in the context of Nr5a2 gene haploinsufficiency, presenting new evidence that microbiome-targeted strategies could offer preventive opportunities for pancreatic disease. Mikhail Chesnokov presented a poster revealing a novel role of the transcription factor NR5A2 in the regulation of intestinal epithelial cell fate and colon homeostasis. In recognition of their contributions, both researchers received travel grants to attend the summit, and Chengsi Wu was appointed as chair of the “Immune Mechanisms in Gastrointestinal Diseases” session.
The DDM Summit brought together leading experts in pancreatic disease research, including Grainne O’Kane, Dieter Saur, Laura Machesky, Andreas Trumpp, and Tuomas Tammela. Other Spanish scientists, including Eduard Batlle (IRB Barcelona), Nabil Djouder (CNIO), and Guadalupe Sabio (CNIO) delivered invited talks on colorectal and liver cancer.
The event fostered a productive exchange between clinicians and basic researchers, highlighting the growing integration of scientific discovery and medical practice within the UEG community.
Through its active participation, ALIPANC reaffirmed its commitment to supporting early-career scientists and promoting excellence in basic and translational research on the mechanisms underlying pancreatic disease. Following its successful debut, the DDM Summit is expected to become a regular feature of future UEG Week meetings.
by Comite Web | Oct 12, 2025 | Sin categorizar
The application period for the ALIPANC 2025 Elections is now open, on the occasion of the renewal of the ALIPANC Directive Board.
Below, we attach the related documentation:
📑 Application_form_ALIPANC2025
📓 Election_rules_ALIPANC2025
by Comite Web | Oct 9, 2025 | Sin categorizar
We share the schedule of upcoming sessions included in our monthly meetings, as well as the scientific activities planned for the coming months:
🔹 2025
🗓️ November 4, 2025
Title: Targeting the KRAS signaling network in pancreatic cancer
Speaker: Vicky Liaki (Barbacid Lab, CNIO, Madrid)
🗓️ December 2, 2025
Title: Development of Neoantigen-based Vaccines in Pancreatic Cancer
Speaker: Núria de la Iglesia (Irsicaixa, Badalona)
🔹 2026
🗓️ January 13, 2026
Title: PREVENPANC. Spanish Multicenter Study for the Prevention of Pancreatic Cancer.
Speaker: Leticia Moreira (Hospital Clínic, Barcelona)
🗓️ February 3, 2026
Title: Variation in CFTR expression can contribute to pancreatic cancer aggressiveness
Speaker: Raquel Ibáñez (VHIR – Xavier Molero Group)
🗓️ March 13, 2026
Event: Third ALIPANC Scientific Meeting. Face-to-face meeting in Madrid, which will give us the opportunity to share experiences, interact and foster new collaborations.
We will provide more details as the schedule is finalized, but we invite you to reserve this date in your calendars.
We encourage all members of the alliance to present their research at upcoming scientific meetings.
Your participation is key to strengthening the collaboration and further advancing our understanding of pancreatic cancer.
by Comite Web | Sep 26, 2025 | Uncategorized
On September 17, at the Ramón Areces Foundation headquarters, Mariano Barbacid and Carmen Guerra, researchers at the Spanish National Cancer Research Center (CNIO), successfully organized the Symposium “Pancreatic Cancer: Challenges and Future Prospects”.
The meeting analyzed advances in pancreatic ductal adenocarcinoma, a cancer with a survival rate of less than 5% at five years, due to late diagnosis and the lack of effective therapies.
The meeting was an opportunity to discuss current major challenges in basic, translational and clinical research; the molecular and cellular origin and evolution of these tumors; the search for new therapies in experimental models; and trials with a new generation of drugs, especially inhibitors of the KRAS oncogene.
Several international experts in the field gathered to address crucial issues in this pathology, of which we highlight:
- Prevention and early detection
– Francisco X. Real highlighted the need for preventive strategies for pancreatic cancer and presented a possible pharmacological pathway to reduce the risk of developing it.
– Nuria Malats presented the molecular relationship between pancreatic cancer, diabetes and obesity.
– Vasiliki Liaki showed positive results of combination therapies in animal models that could lead to future clinical trials.
- New drugs and immunotherapy
– Teresa Macarulla (VHIO) spoke about new therapeutic strategies to improve survival in the next decade.
– Ignacio Garrido-Laguna (University of Utah) presented advances with KRAS oncogene inhibitors and their combination with immunotherapy.
– Peter Bailey (Botton-Champalimaud Center, Lisbon) presented the mechanisms of resistance to chemotherapy and their role in the molecular classification of tumor subtypes (Bailey subtypes).
The aim was to provide an updated view of progress in the study and treatment of pancreatic cancer and to foster international collaborations. For more information about the congress, you can consult the Abstracts book: ABSTRACT BOOK 17 sept.
Or watch the presentations in the following videos of the day: Video 1 , Video 2
